Sopartec supports the commercialization of research-driven innovations from UCLouvain, its affiliated hospitals (CUSL, CHU UCL Namur), and the Institute of Duve by creating spin-offs and licensing deals. It partners with Vives Fund to invest in high-potential startups and spin-offs rooted in academic research.
Preferred startup development maturity for initial funding deployment.
Spin-offs and technology startups originating from UCLouvain research, with a focus on licensing agreements and venture creation in life sciences, healthcare, and applied technology.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...